Operating profit EBITDA: Sanara MedTech Inc. (SMTI)

Graphic logo of sanaramedtech.com (SMTI)

Analyzing the EBITDA chart on GURU.Markets, we see that Sanara MedTech Inc. (SMTI) has stabilized at the 13.95 level. High barriers to entry are ensured by patents and strict FDA control. Sanara MedTech Inc. (SMTI) is developing a comprehensive suite of surgical solutions, integrating its materials into hospital protocols. The advantage of Sanara MedTech Inc. (SMTI) is based on the unique composition of CellerateRX, which accelerates tissue regeneration and minimizes infection risks.

Profit before payment of interest, taxes and amortization: sanaramedtech.com (SMTI) for 11/23/2025 - 11/12/2026

Sanara MedTech (SMTI) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Sanara MedTech, Inc.|SMTI - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Sanara MedTech|SMTI - Enterprise Value
- book value of equity indicators:
Net Assets per Share Sanara MedTech|SMTI - Company Book Value|Capitalization to Book Value Ratio sanaramedtech.com|SMTI - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Sanara MedTech Inc.|SMTI - Long-Term Debt to Capital|Short-Term Debt to Capital Sanara MedTech, Inc.|SMTI - Company Debts|Debt to Book Value Ratio Sanara MedTech|SMTI - Company Long-Term Debts|Company Short-Term Debts Sanara MedTech|Intermediate Coverage Ratio sanaramedtech.com
- company profitability and valuation multiples indicators:
SMTI - Net Profit|Projected Future Earnings Sanara MedTech Inc.|SMTI - Price to Earnings Ratio|Future Price to Earnings Multiple Sanara MedTech, Inc.|SMTI - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Sanara MedTech|SMTI - Operating profit EBITDA|Net earnings per one share for the last twelve months Sanara MedTech|SMTI - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months sanaramedtech.com|SMTI - Net earnings per share growth this year|Projected earnings per share increase next year Sanara MedTech Inc.
Analysis of all company metrics:Sanara MedTech Inc. - SMTI
Signature product of Sanara MedTech

Absolute operating profit in cash reflects the daily cash flow from the core activities of Sanara MedTech Inc. (SMTI) amid expensive liquidity, allowing for the real-time tracking of business efficiency between quarterly reports. An analysis of EBITDA history demonstrates how successfully the implementation of AI automation in biomaterial production optimizes costs and converts technological deployment into real financial results.

Who Sanara MedTech Inc. competes with

Operating income before deduction of amortization Krystal Biotech Corp. (KRYS)|APGE - Profit before payment of interest, taxes and amortization|ARQT - Operating profit EBITDA|VCEL: Operating profit EBITDA|ORKA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization DBV Tech|Operating profit before amortization SLSN (Solesence Inc.)|Profit before payment of interest, taxes and amortization Journey Medical (DERM)|Operating income before deduction of amortization fortebiorx.com|Operating profit EBITDA EMPG (Empro Group)|Operating profit EBITDA Sol-Gel Technologies Ltd SLGL|AXIL - Profit before payment of interest, taxes and amortization|MDCX (Medicus Pharma Corp) - Operating profit before amortization|VRCA: Operating profit EBITDA|Hoth Therapeutics (HOTH) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Biofrontera, Inc.|VYNE: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SNOA|Operating profit EBITDA quoinpharma.com (QNRX)|Azitra, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization DRMA|ELAB - Profit before payment of interest, taxes and amortization|Revance Therapeutics Inc. (RVNC) - Operating profit before deduction of amortization